To evaluate the necessity of MAP3K13 for anchorage-dependent and -independent proliferation in vitro and tumorigenesis in vivo, we examined the effect of targeting MAP3K13 in MB231, HepG2 and MCF-7 cancer cells using specific shRNA. The gene discussed is MAP3K13; the disease is cancer.